首页> 外文期刊>Annals of surgical oncology >Morbidity of the Abdominal Wall Resection and Reconstruction After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
【24h】

Morbidity of the Abdominal Wall Resection and Reconstruction After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

机译:细胞还原手术和高温腹膜内化学疗法(CRS / HIPEC)后腹壁切除和重建的发病率

获取原文
获取原文并翻译 | 示例

摘要

CRS/HIPEC has evolved as a therapeutic option for selected patients with peritoneal surface malignancies. To achieve complete cytoreduction (CC), some patients require extensive abdominal-wall resection (AWR) and subsequent complex reconstructions, which may be associated with wound complications (WC) and delay of postoperative cancer therapy.
机译:CRS / HIPEC已经发展成为某些腹膜表面恶性肿瘤患者的治疗选择。为了实现完全的细胞减少(CC),一些患者需要广泛的腹壁切除(AWR)和随后的复杂重建,这可能与伤口并发症(WC)和术后癌症治疗的延迟有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号